Interview with Bioethicist Dr. Madison Kilbride
Ethical Dilemmas in Genetic Testing
I interviewed Dr. Madison Kilbride for the DNA Today podcast. At the University of Utah, Madison Kilbride, a professor of philosophy specializing in bioethics. Her research focuses on ethical implications of genetic testing, particularly direct-to-consumer (DTC) genetic testing, genetic privacy, and family obligations around genetic information. Her work has been published in top journals, including Journal of American Medical Association, Journal of Clinical Oncology, Hastings Center Report, the American Journal of Bioethics, and the Journal of Medical Ethics. From the ethical limits of DTC genetic testing to the complexities of breaching confidentiality to warn at-risk relatives, in this episode Dr. Kilbride dives into some of the most pressing debates in modern medical ethics.
The discussion consisted of:
Why Dr. Kilbride, a philosopher by training, was drawn to ethical issues in genetics
How direct-to-consumer (DTC) genetic testing has evolved, and the “Goldilocks problem” of too-narrow vs. too-broad test panels
What consumers misunderstand about the limitations of tests like 23andMe’s 3-variant BRCA screen
Dr. Kilbride’s personal experience with a variant reclassification and the ethical duty of testing companies in communicating critical updates
The “principle of rescue” as an ethical framework for when patients should share genetic results with family members
Whether patients have a moral duty to get tested in the first place — particularly if family members might benefit
Ethical implications of sharing information about non-Mendelian or multifactorial traits like autism or diabetes
Pushback against the idea that genetic data is “inherently familial,” and why this philosophical distinction matters
When (if ever) healthcare providers should breach patient confidentiality to warn relatives at risk of a genetic condition
Ethical criteria for deciding whether breaching confidentiality is justified
Why insurance companies should treat IVF with preimplantation genetic testing (PGT) as medically necessary
How IVF-with-PGT compares to preventive care models like cancer screening
Advice for genetic counselors navigating family disclosure and autonomy tensions
Predictions for the future of genetic testing and what ethical frameworks need to evolve now
Thanks for DNA Today for letting me host.